| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1470320313515036 |
| P698 | PubMed publication ID | 24452035 |
| P50 | author | Hiromi Rakugi | Q35703947 |
| Tatsuya Shoji | Q42172695 | ||
| Yoshiharu Tsubakihara | Q43610815 | ||
| Ryohei Yamamoto | Q57697619 | ||
| Yoshitaka Isaka | Q88047549 | ||
| Hirotsugu Iwatani | Q117248692 | ||
| Yasuyuki Nagasawa | Q117248693 | ||
| Enyu Imai | Q117248694 | ||
| Noriyuki Okada | Q117248698 | ||
| Toshiki Moriyama | Q117248699 | ||
| P2093 | author name string | Atsushi Yamauchi | |
| Junya Teranishi | |||
| P2860 | cites work | Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis | Q33562172 |
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. | Q35025450 | ||
| Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome | Q35779949 | ||
| Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. | Q35995685 | ||
| ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? | Q36719942 | ||
| Nationwide survey on current treatments for IgA nephropathy in Japan | Q37467985 | ||
| Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy | Q38472971 | ||
| Functional regulation of Alu element of human angiotensin-converting enzyme gene in neuron cells. | Q39198053 | ||
| Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 | ||
| Survivor treatment selection bias in observational studies: examples from the AIDS literature | Q40983015 | ||
| Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes | Q41573426 | ||
| Cigarette smoking and progression of IgA nephropathy. | Q43062618 | ||
| Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism | Q43074365 | ||
| Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression | Q44152987 | ||
| Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. | Q44366494 | ||
| Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial | Q44449839 | ||
| Molecular basis of human hypertension: role of angiotensinogen | Q45118696 | ||
| A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN). | Q46023346 | ||
| Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. | Q50885930 | ||
| Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 | ||
| A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. | Q53107647 | ||
| Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy. | Q54419152 | ||
| Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy | Q57623228 | ||
| ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1 | Q57703755 | ||
| A candidate gene approach to genetic contributors to the development of IgA nephropathy | Q58363116 | ||
| P433 | issue | 3 | |
| P921 | main subject | endocrinology | Q162606 |
| P304 | page(s) | 633-641 | |
| P577 | publication date | 2014-01-22 | |
| P1433 | published in | Journal of the Renin-Angiotensin-Aldosterone System | Q6296180 |
| P1476 | title | ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy | |
| P478 | volume | 16 |
Search more.